Medical Diagnostic Reagent Manufacturing

The contract pertains to the manufacture of a high-level glucose control solution in 4mL volumes, specifically designed for calibrating and verifying the accuracy of blood glucose meters used in medical diagnostics. This is a subcontract under the NAICS code 325412, which classifies the production of in-vitro diagnostic substances, and is governed by the Department of Defense through its Medical Supply Chain MD SURG FSF subdivision. The solution is a critical component in ensuring the reliability of point-of-care glucose testing devices, requiring strict quality control and consistency to meet clinical standards. The place of performance is designated as West Bath, Maine, with a zip code of 04530, indicating where the manufacturing and associated activities must take place. Responses to the solicitation are due by May 6, 2026, with the request publicly posted on April 30, 2026, providing a six-day window for proposers to submit their offerings. Although no specific set-aside classification or agency point of contact is listed, the solicitation is accessible through the DIBBS platform under the reference number SPE2DS26T038L. The nature of the product, its role in healthcare diagnostics, and the military supply chain context underscore the precision and regulatory compliance required in its production, with performance expectations likely tied to stringent validation protocols and lot-to-lot consistency to support federal healthcare operations.